prostate header graphic
Prostate Problem Guide

Prostate Cancer Stages In Simple Non-Medical Terms

It is extremely important that, following a diagnosis of prostate cancer, the stage and growth rate of the cancer is determined, so that the most suitable form of treatment can be given. This involves determining the spread of the cancer outside of the prostate gland and the manner in which the cancer is growing.

Prostate cancer cells are similar to other body cells in many ways and will go through various stages of growth and there are a number of tests and grading systems which can be used to determine and classify the stage of growth of prostate cancer cells.

A widely used method of grading is known as the Gleason system. In this case cancer cells are compared to normal cells and given a score to indicate their appearance when compared to normal cells. Grading runs from 1 to 5, with 1 representing a cell which is quite close to a normal cell and 5 indicating a cell which bears little resemblance to a normal cell.

Unfortunately cells in different areas of the prostate may be at different stages of development and so, in order to obtain an overall Gleason score, the scores are taken from the two areas which are most affected by cancer and the scores are then added together. This overall score, which will lie between 2 and 10, indicates an increasingly aggressive form of prostate cancer as the score increases.

A commonly used system in determining the extent to which cancer has spread is the TNM system, which uses a combination of the size of the tumor, the extent to which the lymph nodes have been affected and the presence of other related cancers appearing in sites other than the prostate gland.

Using the TNM system prostate cancer is then classified as being T1, T2, T3 or T4 cancer, with T1 and T2 indicating a cancer which is confined to the prostate gland and T3 and T4 indicating a cancer which has spread beyond the prostate gland.

Further information on prostate cancer stages:

GU Cancers Symposium 2012 - Hypofractionation for prostate cancer: Is less ... - UroToday


GU Cancers Symposium 2012 - Hypofractionation for prostate cancer: Is less ...
UroToday
This area of study is based on the fractionation sensitivity (alpha-beta ratio) of prostate cancer. In this presentation, Dr. Lee defined fractionation as: 1) conventional 1.8-2Gy; 2)moderate 2.4-4 Gy; and 3) extreme 6.5-10 Gy.

and more »

Exercise improves survival in cancer patients - Times of India


Press TV

Exercise improves survival in cancer patients
Times of India
"Vigorous physical activity may provide clinical benefits for men diagnosed with early stage prostate cancer," said study author June Chan, professor at the UCSF. The finding is based on two studies conducted earlier by the UCSF and the Harvard School ...
Science Shows How Exercise Might Help in Prostate CancerU.S. News & World Report
Exercise can improve survival in prostate cancer patientsPress TV
Exercise Improves Survival from CancerCalorieLab Calorie Counter News
UCSF Today
all 60 news articles »

Medivation prostate cancer drug well-tolerated in trial - Fox News


MD News

Medivation prostate cancer drug well-tolerated in trial
Fox News
The drug is also being tested in patients with earlier-stage prostate cancer. The safety profile of the drug "looked good with no major red flags," said ISI Group analyst Mark Schoenebaum, adding that the seizure rate "could pose some concern as the ...
Medivation Surges on Prostate Cancer Drug: San Francisco MoverBusinessWeek
New Type of Prostate Cancer Pill Extends LivesWebMD
Targeted Therapy Improves Overall Survival in Men with Late-Stage Prostate CancerHealthCanal.com

all 90 news articles »